{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 460023008
| IUPAC_name = (7''R'')-7-((''Z'')-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((''Z'')-2-(4-methylthiazol-5-yl)vinyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
| image = Cefditoren.svg
| width = 200px
<!--Clinical data-->
| tradename = Spectracef
| Drugs.com = {{drugs.com|monograph|spectracef}}
| MedlinePlus = a605003
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|CAS}}
| CAS_number =  104145-95-1
| ATC_prefix = J01
| ATC_suffix = DD16
| PubChem = 9870843
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 610374
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01066
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 8046534
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 81QS09V3YW
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D07639
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 59343
<!--Chemical data-->
| C=19 | H=18 | N=6 | O=5 | S=3
| molecular_weight = 506.58 g/mol
| smiles = O=C3N2/C(=C(/C=C\c1scnc1C)CS[C@@H]2[C@@H]3NC(=O)C(=N\OC)/c4nc(sc4)N)C(=O)O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H18N6O5S3/c1-8-11(33-7-21-8)4-3-9-5-31-17-13(16(27)25(17)14(9)18(28)29)23-15(26)12(24-30-2)10-6-32-19(20)22-10/h3-4,6-7,13,17H,5H2,1-2H3,(H2,20,22)(H,23,26)(H,28,29)/b4-3-,24-12-/t13-,17-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = KMIPKYQIOVAHOP-YLGJWRNMSA-N
}}

'''Cefditoren''' is a third-generation [[cephalosporin]] [[antibiotic]] for oral use. It is commonly marketed under the trade name '''Spectracef''' by Vansen Pharma Inc.

Cefditoren is also marketed under the name '''Meiact''' by [[Meiji Seika]] Pharma Co., Ltd.<ref>[http://www.12buys.com/fulldescription.asp?Pdesc=Cefditoren&Ptype=Generic&Pchar=Cefditoren Meiact Full Description] {{webarchive|url=https://web.archive.org/web/20100917221510/http://12buys.com/fulldescription.asp?Pdesc=Cefditoren&Ptype=Generic&Pchar=Cefditoren |date=2010-09-17 }}</ref>

==Spectrum of bacterial susceptibility==
Cefditoren has a broad spectrum of activity and has been used to treat bacterial infections of the skin and respiratory tract, including bronchitis, pneumonia, and tonsillitis. The following represents MIC susceptibility data for a few medically significant microorganisms.
* ''Haemophilus influenzae'': ≥0.063 - 0.25 μg/ml
* ''Staphylcoccus aureus'': 0.25 - >128 μg/ml (includes [[Methicillin-resistant Staphylococcus aureus|MRSA]])
* ''Streptococcus pyogenes'': ≤0.004 - 2 μg/ml<ref>http://www.toku-e.com/Assets/MIC/Cefditoren%20sodium.pdf</ref>

Cefditoren is a broad-spectrum antibiotic against Gram-negative and Gram-positive bacteria, but does not have antibacterial activity against ''[[Pseudomonas aeruginosa]]''.<ref>{{cite web |url=https://www.wikigenes.org/e/chem/e/6436125.html |title=Disease relevance of Cefditoren |accessdate=June 24, 2014}}</ref>

==Clinical use==
{{main|Cephalosporin}}

===Indications===
Cefditoren is used to treat uncomplicated skin and skin structure infections, community-acquired [[pneumonia]], acute bacterial exacerbation of [[chronic bronchitis]], [[pharyngitis]], and [[tonsillitis]].

===Formulations===
Cefditoren is available as 200- and 400-mg tablets.  It can be formulated as the [[prodrug]] '''cefditoren pivoxil'''.
[[File:Cefditoren pivoxil.svg|thumb|left|Chemical structure of cefditoren pivoxil]]{{clear-left}}

==References==
{{reflist}}

==External links==
*[http://www.spectracef.com Manufacturer's Product website]
*[https://web.archive.org/web/20071010124606/http://www.purduepharma.com/PI/Prescription/SPECTRACEF.pdf Manufacturer's prescribing information for Spectracef]

{{CephalosporinAntiBiotics}}

[[Category:Cephalosporin antibiotics]]
[[Category:Thiazoles]]